This Pre-Solicitation opportunity from Department Of Veterans Affairs was posted on July 15, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

AJ13--Liposome Preparation for Experimental Rheumatoid Arthritis treatment

Closed

36C24526Q0665Federal

Submission Closed07/31/2026, 01:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Supply of Electrical Insulation Tape (NSN 5970-01-012-4280)This subcontract involves the supply of electrical insulation tape, identified by NSN 5970-01-012-4280, for prime contractors working on DLA Weapons Support ASC projects. The contractor is required to provide two rolls of tape delivered FOB Origin to Evenes Airbase. All materials must strictly conform to technical specification BASIC CID A-A-59474D, Revision D, and adhere to MIL-STD-2073-1E and RP001 for packaging and MIL-STD-129 for marking. To be eligible, the supplier must hold either SAE AS9003 or ISO 9001 certification and maintain full compliance with DFARS 252.204-7012. This procurement is managed by the Department of Defense under the DLA Weapons Support ASC Supplier Oper AE and AF Div, with a response deadline set for November 5, 2026.

DLA WEAPONS SUPPORT ASC SUPPLIER OPER AE AND AF DIV

POSTED

DEADLINE

Sterile X-Ray Detectable Packing Gauze SupplierThis subcontract involves the supply of 640 units of sterile, medical-grade packing gauze for prime contractors supporting Department of Defense medical supply contracts. The required product is a 1-ply, soft, white Z-fold gauze measuring 3 inches by 5 yards, featuring an embedded X-ray detectable line. To ensure clinical safety and longevity, the gauze must be sterilized to medical standards to maintain a shelf life of 60 months. The contract is managed under the Medical Supply Chain MD Surg FSF and requires strict adherence to the Berry Amendment and the Buy American Act for NSN 6510-01-695-5824. Performance for this requirement is centered in San Diego, California. Interested parties must note the response deadline of November 3, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Tolnaftate Powder (USP 1%)This subcontract involves the supply of Tolnaftate Powder, USP 1%, to prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The requirement specifies the delivery of two bottles of pharmaceutical product, with each unit consisting of a 45 GM sealed container. All supplies must strictly adhere to United States Pharmacopeia standards and utilize commercial packaging and packing methods to ensure the integrity of the contents. The opportunity is categorized under NAICS code 325412 and is associated with a performance location in FPO 96678. Interested parties must note the response deadline of November 3, 2026, following the posting date of October 28, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Disposable PVP Iodine ApplicatorsThis subcontract involves the supply of individually packaged disposable PVP Iodine swab sticks to prime contractors supporting Department of Defense medical supply contracts through DLA Troop Support. The required product must match NSN 6515-01-519-2226, utilizing medical-grade Povidone-Iodine solution and medical-grade packaging. Each delivery unit consists of packages containing 50 applicators. Strict quality and timing standards are mandated, requiring a minimum shelf life of 15 months and delivery within two months of the date of manufacture. The contract is categorized under NAICS code 325412 and is managed by the Medical Supply Chain MD Surg FSF. Performance for this requirement is designated for FPO 09592-4700.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Calcium Carbonate Chewable TabletsThis subcontract involves the supply of regular strength, peppermint-flavored calcium carbonate chewable tablets for prime contractors supporting the Department of Defense via the Medical Supply Chain Pharm FSA. The requirement specifies 500 MG tablets provided in bottles of 150 count, with a total delivery of 10 bottles. All products must adhere to a non-extendable shelf life of 36 months under Type I, Code Q specifications. The provider must maintain pharmaceutical manufacturing qualifications and ensure full FDA compliance for over-the-counter medications. Performance for this contract is designated for Fort Stewart, Georgia. Interested parties must respond by November 3, 2026, in accordance with the solicitation guidelines.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Lidocaine Hydrochloride and Dextrose Injection ManufacturerThis subcontract involves the manufacture and supply of sterile, nonpyrogenic Lidocaine Hydrochloride and Dextrose Injection to support prime contractors fulfilling Department of Defense supply contracts through the Medical Supply Chain Pharm FSA. The production process requires compounding 2g of Lidocaine Hydrochloride USP and 5g of Hydrous Dextrose USP with Water for Injection USP to achieve a 500 ML bag fill volume. All manufacturing must occur in sterile compounding environments using containers that are latex-free, DEHP-free, and PVC-free to ensure full compliance with USP standards and FDA requirements. The performance of this contract is based in Williamsburg, Virginia, under NAICS code 325412. The scope of work concludes with the delivery of finished sterile injection bags. Interested parties should note the response deadline of November 3, 2026, for this specific procurement opportunity.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Chlorine Dioxide Water Purification TabletsThis subcontract involves the supply of stabilized chlorine dioxide water purification tablets for prime contractors supporting Department of Defense projects under the DLA Troop Support Medical Supply Chain. The required tablets must contain no active chlorine or iodine and be delivered in units of 10 individually sealed tablets per package. To ensure operational readiness, the product must maintain a 60-month shelf life and adhere strictly to Medical Marking Standard No. 1 and MIL-STD-2073-1E. The scope of work requires the delivery of 10 packages of tablets on a FOB Destination basis. The project is categorized under NAICS code 325412 and is managed by the Medical Supply Chain Pharm FSA. Performance for this contract is designated for APO 96319-5024.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Electrical Insulation Tape (NSN 5970010124280)This subcontract involves the supply of electrical insulation tape to prime contractors supporting Defense Logistics Agency Weapons Support aviation supply contracts. The requirement is for two rolls of tape in 36-yard units that strictly adhere to NSN 5970010124280 specifications. The contractor must ensure rigorous quality control and logistics compliance, performing sampling according to MIL-STD-1916 or ASQ H1331 Table 1. Additionally, all materials must be packaged and marked in accordance with MIL-STD-2073-1E, RP001, and MIL-STD-129 standards. This opportunity falls under NAICS code 325412 and is managed by the Department of Defense.

Defense Logistics Agency

POSTED

DEADLINE

Supplier of Multi-Parameter Urine Test Strips and Color ChartsThis subcontract opportunity is for the supply of multi-parameter urine test strips and corresponding color charts to support prime contractors on DLA Troop Support Medical Supply Chain projects for the Department of Defense. The required medical-grade strips must be capable of analyzing bilirubin, blood, glucose, ketone, leukocytes, nitrite, pH, protein, specific gravity, and urobilinogen. All products must strictly adhere to Regulation 862.1340 Class II and Medical Marking Standard No. 1, and must be delivered in bottles of 100 strips with a minimum shelf life of 18 months. The procurement falls under NAICS code 325412 and is managed by the Medical Supply Chain MD SURG FSF. The place of performance is designated as FPO 09592-4700. Interested parties should note the posted date of October 28, 2026, with a response deadline set for November 3, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Salicylic Acid Plaster SupplierThis subcontract involves the manufacture and supply of Salicylic Acid Plasters for prime contractors serving the Department of Defense Medical Supply Chain. The required plasters must measure 5.08 cm by 7.62 cm, feature a flannel back, and consist of a composition of 40 percent salicylic acid and 60 percent base. Each order must be packaged in units of 25 and maintain a minimum shelf life of 24 months. The supplier is responsible for delivering items under NSN 6510011202643 while ensuring full compliance with MIL-STD-129 and DFARS 252.225-7001 standards. Performance for this contract is designated for FPO 09592-4700, with the procurement falling under NAICS code 325412.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Salicylic Acid Gel SupplierThis subcontract involves the supply of 17 percent concentration Salicylic Acid Gel in 7 gram tubes for prime contractors supporting Department of Defense projects under the DLA Troop Support Medical Supply Chain. The supplier is responsible for manufacturing or sourcing the gel to exact concentration specifications and ensuring all packaging meets MIL-STD-2073-1E and RP001 medical-grade tubing standards. Additionally, the provider must adhere to Medical Marking Standard No. 1 and maintain Medical Controlled Room Temperature throughout the transport process. The contract is categorized under NAICS code 325412 and requires the delivery of the finished pharmaceutical product FOB Destination. Performance for this requirement is centered at Fort George G Meade. Interested parties must note the response deadline of November 3, 2026, for this medical supply chain procurement.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Isopropyl Alcohol (99% Isopropanol) SupplierThis subcontract involves the sourcing and manufacture of medical-grade 99 percent Isopropyl Alcohol to support prime contractors for the Department of Defense Medical Supply Chain Pharm FSA. The supplier is responsible for ensuring that all isopropanol meets USP Over-the-Counter standards and is produced using USP grade chemical materials within compliant bottling facilities. Key deliverables include the provision of the alcohol in bottles along with Safety Data Sheets for approval by the contracting officer. The performance of this contract is centered in FPO 96672, with a response deadline set for November 3, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 23 hours ago

DEADLINE

in 5 days

AI Contract Overview

The Department of Veterans Affairs, through Network Contracting Office 05, is preparing to issue a solicitation for the development and characterization of custom liposomal formulations designed for targeted delivery of an anti-arthritis drug to joints, leveraging proprietary VA-owned lipid compositions and a patented targeting peptide known as ART2. This effort supports experimental rheumatoid arthritis therapy research and requires a contractor with demonstrated expertise in nanoparticle formulation, surface functionalization with peptides, encapsulation of therapeutic agents, and comprehensive analytical characterization including particle size, zeta potential, polydispersity index, and drug quantification via LC MS/MS or HPLC. Full technical specifications including lipid ratios and ART2 conjugation protocols will only be disclosed after execution of a Confidential Disclosure Agreement with the VA Technology Transfer Program, ensuring protection of patented intellectual property. Contractors must be capable of producing research-grade liposomal systems with certified analysis documentation and delivering materials suitable for non-GLP exploratory studies. The solicitation, expected to be posted on SAM.gov under solicitation number 36C24526Q0665, will outline detailed performance requirements, evaluation criteria, and procedural guidance for accessing proprietary information. Interested parties must monitor SAM.gov for the official release and understand that no responses are solicited at this pre-solicitation stage, nor will the government reimburse any preparatory costs. All inquiries must be directed to the designated contracting officer via email only, and no phone contact is permitted. Selection of vendors will require completion of a CDA prior to receipt of sensitive technical details.

General Info

VA seeks contractor to develop custom liposomal arthritis drug delivery using patented lipids and ART2 peptide.

Agency

Department Of Veterans Affairs → 245-NETWORK Contract Office 5 (36C245)

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

Contractor's facility / laboratory, MD, 20422, USA

Set-Aside

NONE

Documents

Pre-Solicitation Notice for Liposome Preparation for Arthritis Therapy - 36C24526Q0665

presolicitation

Low

Sources Sought Notice 36C24526Q0665 - Liposome Preparation for Arthritis Therapy

sources-sought

Low

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedJul 14

Sources Sought

Type ChangedJul 15

Sources Sought → Presolicitation

Response DeadlineJul 31

Deadline has passed

Submission Closed

07/31/2026, 01:00:00 PM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Veterans Affairs → 245-NETWORK Contract Office 5 (36C245)

Contacts1 person available

OfficeLINTHICUM, MD, 21090, USA

Organization / AgencyDepartment Of Veterans Affairs → 245-NETWORK Contract Office 5 (36C245)

Office AddressLINTHICUM, MD, 21090, USA

Contacts

Robert O'Keefe JrContracting Officer

contact@example.gov

Full Description

PRE SOLICITATION NOTICE
Department of Veterans Affairs Network Contracting Office 05 (NCO 05) Joint Targeted Drug Delivery Approach for Arthritis Therapy Liposome Preparation NAICS: 325412 Pharmaceutical Preparation Manufacturing PSC: AJ13 R&D Biomedical, Advanced Development
1. Announcement
The Department of Veterans Affairs, Network Contracting Office (NCO) 05, intends to issue a solicitation for the preparation and characterization of specialized liposomal formulations incorporating patented joint targeting technologies. This notice serves as a Pre Solicitation Notice only and is issued in accordance with FAR 5.204.
This notice is not a request for quotes or proposals, and no responses are required at this time.
2. Summary of Requirement
The forthcoming solicitation will seek a qualified contractor capable of producing research grade liposomes utilizing: A patented lipid composition A patented joint targeting peptide (ART2) Encapsulation of an anti arthritis drug Standard physicochemical characterization of nanoparticle/liposome systems This work supports VA owned intellectual property associated with an experimental drug delivery system intended for arthritis therapy. Full technical details, including lipid composition, ratios, and ART2 functionalization methods will be released only after completion of a Confidential Disclosure Agreement (CDA) with the VA Technology Transfer Program.
3. Anticipated Contractor Capabilities
The forthcoming solicitation will require vendors with demonstrated capability in: Custom nanoparticle or liposome formulation using sponsor specified lipid systems Peptide or ligand functionalization of nanoparticle surfaces Drug encapsulation and documentation of encapsulation efficiency Analytical nanoparticle characterization (particle size, zeta potential, PDI, drug loading) LC MS/MS or HPLC drug quantification Delivery of research grade formulations for non GLP exploratory studies Production of Certificates of Analysis (COA) for liposomal drug systems
4. Security and Intellectual Property Restrictions
The lipid composition and ART2 peptide functionalization process are proprietary and patented by the VA. Distribution of proprietary information will require: Execution of a Confidential Disclosure Agreement (CDA) with the VA Technology Transfer Program prior to release of any technical specifications.
5. Solicitation Release Information
The formal solicitation (Request for Quote or Request for Proposal) is expected to be posted on SAM.gov. The solicitation will include: Detailed performance requirements Instructions to offerors Evaluation criteria CDA instructions for accessing proprietary specifications Vendors are responsible for monitoring SAM.gov for updates.
6. Point of Contact
Contracting Officer: Robert O Keefe Jr. Email: contact@example.gov
No phone inquiries will be accepted. All questions will be addressed after formal solicitation issuance.
7. Disclaimer
This Pre Solicitation Notice does not constitute a solicitation. It does not request proposals or quotes and does not obligate the Government to award a contract. The VA will not reimburse any costs associated with preparation or submission of information in response to this notice. Upon completion of market research and release of the solicitation, selected vendors will be required to sign a Confidential Disclosure Agreement (CDA) prior to receiving proprietary materials and full technical specifications.